Health Canada approves Moderna's mRNA RSV vaccine, company says

  • 📰 CP24
  • ⏱ Reading Time:
  • 21 sec. here
  • 4 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 67%

Health 뉴스

National,Social

Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older.

Moderna says Health Canada has approved its mRNA vaccine, shown in a handout photo, to protect against respiratory syncytial virus in adults age 60 and older. THE CANADIAN PRESS/HO-Moderna **MANDATORY CREDIT**

In a news release, Moderna said it expects the RSV vaccine — called mRESVIA — to be available in early 2025. Earlier this year, the National Advisory Committee on Immunization recommended RSV immunization for adults 75 years and older. According to the Public Health Agency of Canada's wastewater surveillance, the level of RSV circulating is currently"moderate" across much of the country.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 30. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
출처: SooToday - 🏆 8. / 85 더 많은 것을 읽으십시오 »

Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
출처: BurnabyNOW_News - 🏆 14. / 77 더 많은 것을 읽으십시오 »

Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
출처: PGCitizen - 🏆 65. / 51 더 많은 것을 읽으십시오 »

Health Canada approves Moderna’s mRNA RSV vaccine, company saysHealth Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older.
출처: CHEK_News - 🏆 59. / 55 더 많은 것을 읽으십시오 »

Health Canada approves Moderna's mRNA RSV vaccine, company saysHealth Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older, available next year.
출처: CTVNews - 🏆 1. / 99 더 많은 것을 읽으십시오 »

Health Canada approves Moderna’s mRNA RSV vaccine, company saysAgency approves the vaccine to protect against respiratory syncytial virus in adults age 60 and older
출처: globeandmail - 🏆 5. / 92 더 많은 것을 읽으십시오 »